Your email has been successfully added to our mailing list.

×
0 0 0 -0.0277777777777778 -0.0277777777777778 -0.00925925925925927 -0.00925925925925927 -0.0185185185185185
Stock impact report

XTL announces receipt of Nasdaq notification [Seeking Alpha]

XTL Biopharmaceuticals Ltd. - American Depositary Shares (XTLB) 
US:NASDAQ Investor Relations: xtlbio.com
Company Research Source: Seeking Alpha
with the continued listing requirements to maintain the minimum $2.5M in stockholders' equity. Nasdaq said its determination was based on the company's Dec. 30, 2025, Form 6-K showing a $47,000 stockholders' equity deficit and its failure to meet alternative listing standards as of Jan. 20, 2026. The company said it is evaluating options to regain compliance and intends to do so within Nasdaq's required timeframe. More on XTL Biopharmaceuticals Seeking Alpha's Quant Rating on XTL Biopharmaceuticals Financial information for XTL Biopharmaceuticals Recommended For You More Trending News Show less Read more
Impact Snapshot
Event Time:
XTLB
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
Last price at news event
Since Event
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
Last Price
VWAP
High:
Max Up
High:
Low:
Max Down
Low:
%
Post news range
%
Price change

Price Change Percentage


S&P 500
(SPX)

%

Volume ratio
%

Volume
Ticks

Avg transaction size

Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Opt-in for XTLB alerts
Opt-in for
XTLB alerts

from News Quantified
Opt-in for
XTLB alerts

from News Quantified